PDRN (Polydeoxyribonucleotide) for diabetic foot ulcers

Posted on February 4, 2014 by admin

THE EFFECT OF PDRN, AN ADENOSINE RECEPTOR A2A AGONIST, ON THE HEALING OF CHRONIC DIABETIC FOOT ULCERS: RESULTS OF A CLINICAL TRIAL Francesco Squadrito, et al The Journal of Clinical Endocrinology & Metabolism; Ahead of Print Quote: Context: Foot ulcer is the principal cause of hospitalization for patients with diabetes. Polydeoxyribonucleotide (PDRN), an adenosine A2A receptor agonist, improves wound healing in diabetic mice. Objective: Aim of this study was to evaluate the effect of PDRN on chronic ulcer healing in patients with diabetes

Read the rest here:
PDRN (Polydeoxyribonucleotide) for diabetic foot ulcers

Related posts:

  1. Dipeptidyl peptidase 4 inhibition may facilitate healing of diabetic foot ulcers
  2. Dipeptidyl peptidase 4 inhibition may facilitate healing of diabetic foot ulcers
  3. ACE Inhibitors and Diabetic Foot Ulcers
  4. Transdermal oxygen therapy for diabetic foot ulcers
  5. LeucoPatch™ for Diabetic Foot Ulcers
  6. Alginate dressings for healing diabetic foot ulcers
  7. Leptin and diabetic foot ulcers
  8. Leptin and diabetic foot ulcers
  9. Hydrocolloid dressings for healing diabetic foot ulcers
  10. Alginate dressings for healing diabetic foot ulcers
  11. Natural extract for diabetic foot ulcers
  12. Royal Jelly for diabetic foot ulcers
  13. The role of surgical debridement in healing of diabetic foot ulcers
  14. Hydrocolloid dressings for healing diabetic foot ulcers
  15. Royal Jelly for diabetic foot ulcers
This entry was posted in Podiatry Arena. Bookmark the permalink.

Leave a Reply

Your email address will not be published. Required fields are marked *